TIBER CREEK GROUP

Lobbying for AMGEN INC

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Medicare/Medicaid

Issues related to Medicare and Medicaid drug pricing; Issues related to biosimilar access and affordability.

Health Issues

Issues related to the 340B Program - Public Health Service Act (P.L. 78-410).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.